Barry P. Flannelly - 06 Nov 2024 Form 4 Insider Report for INCYTE CORP (INCY)

Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Issuer symbol
INCY
Transactions as of
06 Nov 2024
Net transactions value
-$35,491
Form type
4
Filing time
08 Nov 2024, 12:48:59 UTC
Previous filing
17 Jul 2024
Next filing
11 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INCY Common Stock Options Exercise $102,912 +1,424 +2.5% $72.27 59,466 06 Nov 2024 Direct
transaction INCY Common Stock Options Exercise $154,807 +2,256 +3.8% $68.62 61,722 06 Nov 2024 Direct
transaction INCY Common Stock Sale $116,768 -1,424 -2.3% $82.00 60,298 06 Nov 2024 Direct
transaction INCY Common Stock Sale $176,442 -2,256 -3.7% $78.21 58,042 06 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INCY Employee Stock Option (right to buy) Options Exercise $0 -1,424 -100% $0.000000 0 06 Nov 2024 Common Stock 1,424 $72.27 Direct F2
transaction INCY Employee Stock Option (right to buy) Options Exercise $0 -2,256 -100% $0.000000 0 06 Nov 2024 Common Stock 2,256 $68.62 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This includes an aggregate of 46,105 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
F2 Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.
F3 Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years.